Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
P. Murali Doraiswamy, MD: Alzheimer’s Disease and the Glutamate NMDA Receptor
1
x
$
30.00
David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder
1
x
$
30.00
Todd Lencz, PhD: Neurodevelopmental Models of Schizophrenia: Pathophysiologic Synthesis and Directions for Intervention Research
1
x
$
30.00
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
1
x
$
30.00
Desvenlafaxine and Venlafaxine Exert Minimal In Vitro Inhibition of Human Cytochrome P450 and P-Glycoprotein Activities
1
x
$
30.00
Diagnosis and Treatment of Depression in the Cancer Patient
1
x
$
0.00
Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?
1
x
$
30.00
Branimir Margetic: A Case of Stuttering During Treatment with Levomepromazine
1
x
$
30.00
Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action
1
x
$
30.00
A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae
1
x
$
30.00
Ripu D. Jindal, MD: Effects of Tranylcypromine on the Sleep of Patients with Anergic Bipolar Depression
1
x
$
30.00
Psychosocial Interventions for Bipolar Disorder: A Review of Literature and Introduction of the Systematic Treatment Enhancement Program
1
x
$
30.00
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
1
x
$
30.00
Complete Resolution of Clozapine-Induced Sialorrhea with Low Dose Trihexyphenidyl
1
x
$
30.00
Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?
1
x
$
30.00
Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
1
x
$
30.00
Lamotrigine Adjunctive Therapy to Lithium and Divalproex in Depressed Patients with Rapid Cycling Bipolar Disorder and a Recent Substance Use Disorder: A 12-week, Double-Blind, Placebo-Controlled Pilot Study
1
x
$
30.00
View Cart
Checkout
Home
Store
You cannot add another "Diagnosis and Treatment of Depression in the Cancer Patient" to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
$
30.00
Add to cart
Details
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
$
30.00
Add to cart
Details
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
$
30.00
Add to cart
Details
Off-Label Second Generation Antipsychotics for Impulse Regulation Disorders: A Review
$
30.00
Add to cart
Details
Signal Detection and Placebo Response in Schizophrenia: Parallels with Depression
$
30.00
Add to cart
Details
Thomas J. Raedler, MD: Lithium-Induced Nephropathies
$
30.00
Add to cart
Details
El libro negro de dosificación y monitoreo de sustancias psicotrópicas
$
30.00
Add to cart
Details
Neuropsychiatry of Histaminergic Circuits: Potential Role of Novel H3 Receptor Selective Antagonist/ Inverse Agonist Pitolisant in Prader-Willi Syndrome
$
30.00
Add to cart
Details
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide
$
30.00
Add to cart
Details
Alzheimer’s and Dementia Guidelines and Tables
$
30.00
Add to cart
Details
A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5–12
$
30.00
Add to cart
Details
Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis
$
30.00
Add to cart
Details
Top-Up Clozapine for Risperidone LAI-Related Acute Dystonia and TR Bipolar in an Adolescent with ID-Putting the Cart before the Horse?
$
30.00
Add to cart
Details
Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis
$
30.00
Add to cart
Details
Characteristics of Inpatients Prescribed Dopamine Receptor Blocking Agents
$
30.00
Add to cart
Details
Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study
$
30.00
Add to cart
Details
Lamotrigine and Stevens-Johnson Syndrome Prevention
$
30.00
Add to cart
Details
A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms
$
30.00
Add to cart
Details
Antiepileptic Drugs and Bone Health: Current Concepts (OPEN ACCESS)
$
0.00
Add to cart
Details
Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital
$
30.00
Add to cart
Details
Previous
1
…
5
6
7
…
44
Next
Page load link
Go to Top
